Update in Pulmonary Medicine
Authors: Talmadge E. King Jr.
Journal: Annals of Internal Medicine (1998)

Updates15 November 1998Update in Pulmonary MedicineTalmadge E. King Jr., MDTalmadge E. King Jr., MD1998-99 Series; John Roberts, MD, EditorFrom San Francisco General Hospital, San Francisco, California.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-129-10-199811150-00012 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Pulmonary medicine involves many diseases that overlap with those of other subspecialties. In this report, I focus on important recent developments in three areas: community-acquired pneumonia, organizing pneumonia, and interstitial lung diseases. Other Updates in this series have addressed emerging issues in pulmonary medicine, including thromboembolic diseases, other infections, respiratory diseases in elderly persons, and asthma [1-3].Community-Acquired PneumoniaPneumonia remains one of the “captains of death,” as Sir William Osler once called it. It is the leading cause of death from infection and is the sixth leading cause of death overall. In the United States, 4 million adults-1.5% of ...References1. Levinson W, Roach K, Altkorn D, Stern S. Update in general internal medicine. Ann Intern Med. 1998; 129:212-20. Google Scholar2. Hall WJ. Update in geriatrics. Ann Intern Med. 1998; 129:387-93. Google Scholar3. Bartlett JG. Update in infectious diseases. Ann Intern Med. 1998; 129:464-71. Google Scholar4. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service. Q J Med. 1987; 62:195-220. Google Scholar5. Marrie TJ. Epidemiology of community-acquired pneumonia in the elderly. Semin Respir Infect. 1990; 5:260-8. Google Scholar6. Niederman MS, Bass JB Jr, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis. 1993; 148:1418-26. Google Scholar7. Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997; 155:242-8. Google Scholar Author, Article, and Disclosure InformationAuthors: Talmadge E. King Jr., MDAffiliations: 1998-99 Series; John Roberts, MD, EditorFrom San Francisco General Hospital, San Francisco, California.Corresponding Author: Talmadge E. King Jr., MD, Department of Medicine, San Francisco General Hospital, 1001 Potrero Avenue, Room 5H22, San Francisco, CA 94110.Current Author Addresses: Dr. King: Department of Medicine, San Francisco General Hospital, 1001 Potrero Avenue, Room 5H22, San Francisco, CA 94110. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung FibroblastsTransforming growth factor-β inhibits IQ motif containing guanosine triphosphatase activating protein 1 expression in lung fibroblasts via the nuclear factor-κB signaling pathwaySphingolipids in pulmonary fibrosisTransforming growth factor β regulates β-catenin expression in lung fibroblast through NF-κB dependent pathwayThe Mitochondrial Cardiolipin Remodeling Enzyme Lysocardiolipin Acyltransferase Is a Novel Target in Pulmonary FibrosisTransforming Growth Factor-Beta Inhibits Heme Oxygenase-1 Expression in Lung Fibroblasts through Nuclear Factor-Kappa-B-Dependent PathwayLysophosphatidic Acid Receptor–2 Deficiency Confers Protection against Bleomycin-Induced Lung Injury and Fibrosis in MiceTargeting sphingosine kinase 1 attenuates bleomycin‐induced pulmonary fibrosisLung transplantation in the fischer 344–wistar kyoto strain combination is a relevant experimental model to study the development of bronchiolitis obliterans in the ratOverexpression of α1-protease Inhibitor and Galectin-1 in Radiation-induced Early Phase of Pulmonary FibrosisGene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humansGlobal analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosisCorrection: Update in Pulmonary Medicine 15 November 1998Volume 129, Issue 10Page: 806-812KeywordsAntimicrobialsCorticosteroid therapyHospitalizationsInterstitial lung diseasesLungsPneumoniaPulmonary fibrosisSarcoidosisThoraxTreatment guidelines ePublished: 15 August 2000 Issue Published: 15 November 1998 Copyright & PermissionsCopyright © 1998 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...